United States · FDA National Drug Code directory

SODIUM POLYSTYRENE SULFONATE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 11534-166_c5432731-23bc-44cf-bfcc-e59d16437db2
Product NDC: 11534-166
Form: POWDER, FOR SUSPENSION
Composition / generic term: sodium polystyrene sulfonate
Labeler: SUNRISE PHARMACEUTICAL, INC.
Marketing category: ANDA
Marketing start / end (source format): 20170124
Source listing expiry: 20261231

Source-listed ingredients

SODIUM POLYSTYRENE SULFONATE — 4.1 meq/g

These values do not establish equivalence or a dose recommendation.

Packages

15 g in 1 BOTTLE (11534-166-15) · 11534-166-15
15 g in 1 BOTTLE (11534-166-16) · 11534-166-16
454 g in 1 JAR (11534-166-44) · 11534-166-44

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →